Sarabi A, Hoffer B J, Olson L, Morales M
Cellular Neurophysiology, National Institute on Drug Abuse, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA.
J Comp Neurol. 2001 Dec 10;441(2):106-17. doi: 10.1002/cne.1400.
Glial cell line-derived neurotrophic factor (GDNF) is a survival factor for several types of neurons, including dopaminergic (DAergic) neurons. GDNF binds with high affinity to the GDNF family receptor alpha-1 (GFRalpha-1), which is highly expressed in the midbrain. Using anatomical and lesion techniques, we demonstrated that GFRalpha-1 was expressed in DAergic and non-DAergic neurons in the rat midbrain. Immunohistochemical characterization of GFRalpha-1-expressing neurons indicated that most of the neurons that were immunopositive for the DAergic marker tyrosine hydroxylase (TH) expressed GFRalpha-1 in the substantia nigra pars compacta (SNC). In contrast, fewer TH-containing neurons expressed GFRalpha-1 in the substantia nigra pars reticulata (SNR) and the ventral tegmental area (VTA). Depletion of GFRalpha-1/TH neurons was observed in the SNC following treatment with the neurotoxin 6-hydroxydopamine (6-OHDA); however, GFRalpha-1 expression remained in some neurons located in the SNR. The gamma-aminobutyric acid (GABA)ergic nature of GFRalpha-1-expressing neurons located in the SNR, which were resistant to (6-hydroxydopamine) 6-OHDA, was established by their expression of glutamic acid decarboxylase (GAD; the synthesizing enzyme for GABA). Further analysis indicated that coexpression of GFRalpha-1 and GAD varied in a rostrocaudal gradient in the SNR, substantia nigra pars lateralis (SNL), and VTA. Midbrain DAergic and GABAergic neurons have been previously classified according to their Ca(2+) binding protein (CaBP) content; thus, we also sought to investigate the proportion of midbrain GFRalpha-1-expressing neurons containing parvalbumin (PV), calbindin (CB), and calretinin (CR) in the midbrain. Although GFRalpha-1 expression was found mainly in CB- and CR-immunoreactive neurons, it was rarely observed in PV-immunolabeled neurons. Analysis of the proportion of GFRalpha-1-expressing neurons for each CaBP subpopulation indicated the coexistence of GFRalpha-1 with CR in the VTA and all subdivisions of the SN; double-labeled GFRalpha-1/CR neurons were distributed in the SNC, SNR, SNL, and VTA. GFRalpha-1/CB neurons were also detected in the SNC, SNL, and VTA. Expression of GFRalpha-1 in DAergic and non-DAergic neurons in the rat SN and VTA suggests that GDNF, via GFRalpha-1, might modulate DAergic and GABAergic functions in the nigrostriatal, mesolimbic, and nigrothalamic circuits of the adult rat.
胶质细胞系源性神经营养因子(GDNF)是包括多巴胺能(DAergic)神经元在内的多种类型神经元的存活因子。GDNF与GDNF家族受体α-1(GFRalpha-1)高亲和力结合,GFRalpha-1在中脑高表达。利用解剖学和损伤技术,我们证明GFRalpha-1在大鼠中脑的多巴胺能和非多巴胺能神经元中表达。对表达GFRalpha-1的神经元进行免疫组织化学特征分析表明,在黑质致密部(SNC)中,大多数对多巴胺能标志物酪氨酸羟化酶(TH)呈免疫阳性的神经元表达GFRalpha-1。相比之下,在黑质网状部(SNR)和腹侧被盖区(VTA)中,含TH的神经元表达GFRalpha-1的较少。在用神经毒素6-羟基多巴胺(6-OHDA)处理后,在SNC中观察到GFRalpha-1/TH神经元减少;然而,GFRalpha-1表达仍存在于SNR中的一些神经元中。位于SNR且对6-羟基多巴胺(6-OHDA)有抗性的表达GFRalpha-1的神经元的γ-氨基丁酸(GABA)能性质,通过其谷氨酸脱羧酶(GAD;GABA的合成酶)的表达得以确定。进一步分析表明,GFRalpha-1和GAD的共表达在SNR、黑质外侧部(SNL)和VTA中呈前后梯度变化。中脑多巴胺能和GABA能神经元先前已根据其钙(2+)结合蛋白(CaBP)含量进行分类;因此,我们还试图研究中脑表达GFRalpha-1的神经元中含有小白蛋白(PV)、钙结合蛋白(CB)和钙视网膜蛋白(CR)的比例。虽然发现GFRalpha-1表达主要在CB和CR免疫反应性神经元中,但在PV免疫标记的神经元中很少观察到。对每个CaBP亚群中表达GFRalpha-1的神经元比例的分析表明,GFRalpha-1与CR在VTA和SN的所有亚区中共存;双标记的GFRalpha-1/CR神经元分布在SNC、SNR、SNL和VTA中。在SNC、SNL和VTA中也检测到GFRalpha-1/CB神经元。大鼠SN和VTA中多巴胺能和非多巴胺能神经元中GFRalpha-1的表达表明,GDNF可能通过GFRalpha-1调节成年大鼠黑质纹状体、中脑边缘和黑质丘脑回路中的多巴胺能和GABA能功能。